Metoprolol Succinate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Metoprolol Succinate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22744
Buy Now

Metoprolol Succinate Prices December 2023

Product
Category Region Price
Metoprolol Succinate Pharma API USA 57740 USD/MT (USP FDA)
Metoprolol Succinate Pharma API China 57015 USD/MT (USP FDA)
Metoprolol Succinate Pharma API Germany 58665 USD/MT (USP FDA)


In Q4 2023, metoprolol succinate prices reached 57740 USD/MT. During the fourth quarter, the metoprolol succinate market has shown significant fluctuations in prices amid economic pressures. December witnessed a significant price drop mainly driven by the declining demand from key sectors and waning consumer confidence. This led to an oversupply promoting manufacturers and distributors to lower the prices to offload excess inventory.

During Q4 2023, the Chinese market for metoprolol succinate has shown volatile conditions. Prices saw a moderate increase in October and November mainly driven by limited supplies and increased consumer demand during the festive season. In December prices fell because of decreased inquiries from downstream industries and sluggish export activities. In Q4 2023 price of metoprolol succinate reached 57015 USD/MT.

In Q4 2023 metoprolol succinate market reached 58665 USD/MT. The prices for metoprolol succinate were affected by the decline in demand from end users mainly in health care and pharmaceutical sectors and also due to abundant supply in the market.

Metoprolol Succinate Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Metoprolol Succinate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of metoprolol succinate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing metoprolol succinate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Metoprolol Succinate Price Trend

Metoprolol Succinate Market Analysis

The global metoprolol succinate market size reached 78.1 Thousand Tonnes in 2023. By 2032, IMARC Group expects the market to reach 105.5 Thousand Tonnes, at a projected CAGR of 3.40% during 2023-2032.

  • The rising incidence of cardiovascular diseases such as hypertension, heart attacks, and arrhythmias significantly propel the demand for effective treatment options like metoprolol succinate. As these heart-related conditions are becoming more prevalent, mainly in aging populations and in the regions with increasing health awareness necessitates the need for reliable and accessible medications. According to a report by the World Health Organization (WHO), cardiovascular diseases are one of the leading causes of death globally. Approximately 17.9 million people die every year due to cardiovascular disease. Metoprolol succinate is generally known for its efficacy in managing these cardiovascular diseases. It is increasingly sought after both in established and emerging markets, thereby driving the metoprolol succinate market growth.
  • The aging of the global population is also a significant factor influencing healthcare trends, mainly in the demand for medications such as beta-blockers, including metoprolol succinate. According to a report published by World Health Organization (WHO), by the year 2030, one in six people will be aged 60 years or older. Older people are more prone to develop chronic heart-related diseases like hypertension, arrhythmias, and heart failure. These conditions necessitate effective long-term management strategies for which beta blockers are the cornerstone treatment because of their proven efficacy in reducing heart strain and preventing complications thereby propelling the metoprolol succinate market growth.
  • Moreover, public health initiatives launched by governments and non-governmental organizations aimed at combating heart disease significantly propelled the demand for medications like metoprolol succinate. These initiatives often include widespread screening programs to identify individuals at risk of cardiovascular conditions early in their progression. For instance, the Government of India has launched the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), which is implemented for interventions up to the district level under the National Health Mission. NPCDCS has a focus on awareness generation for behaviour and lifestyle changes, screening and early diagnosis of persons with high levels of risk factors, and their treatment and referral (if required) to higher facilities for appropriate management of Non-communicable Diseases (NCDs), including cardiovascular diseases. By catching heart issues early, these programs facilitate timely intervention, which typically includes the prescription of beta blockers among other treatments, thereby driving the metoprolol succinate market growth.

Metoprolol Succinate News

The report covers the latest developments, updates, and trends impacting the global metoprolol succinate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in metoprolol succinate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the metoprolol succinate industry:

  • In 2024, AstraZeneca has completed an equity investment of $140 million in Cellectis, a clinical-stage biotechnology company, bringing AstraZeneca's total equity stake in Cellectis to approximately 44%. The collaboration will leverage Cellectis' gene editing technologies and manufacturing capabilities to develop up to 10 novel cell and gene therapy products for areas of high unmet need, including oncology, immunology, and rare diseases.
  • In 2022, Lannett Company, Inc. has announced patent licenses for a pen injector delivery device to be utilized in its insulin glargine and insulin aspart development program, enhancing its pharmaceutical product offerings. This strategic move aims to bolster Lannett's position in producing safe, effective, and affordable pharmaceutical products for patients and customers, aligning with its commitment to quality and innovation.

Product Description

Metoprolol succinate is a beta-blocker medication that is primarily used to manage hypertension, angina, and heart rhythm disorders. It works by blocking the effects of adrenaline on the heart and blood vessels, thereby reducing heart rate, blood pressure, and strain on the heart. This drug is a more extended-release form of metoprolol, allowing for once-daily dosing. This feature can improve patient compliance compared to medications requiring multiple doses per day. Moreover, it is commonly prescribed after heart attacks to prevent further cardiac events. Additionally, metoprolol succinate can be used off-label to help control symptoms of anxiety and to prevent migraine headaches. Its role in managing these conditions makes it a versatile and vital medication in clinical medicine. The drug's effectiveness and safety profile have made it a cornerstone in the treatment of various heart-related ailments.

Regional Coverage

The report provides a detailed analysis of the metoprolol succinate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.

Global Metoprolol Succinate Price

The report offers a holistic view of the global metoprolol succinate pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Metoprolol Succinate Price

Metoprolol succinate prices in the European region were affected by several factors in Q4 2023. These included a decline in demand due to inflationary pressures and high interest rates, surplus supply, and Germany's market dynamics. The price trends showed a slight increase in November and a decrease in December, with no significant variation between the first and second halves of the quarter.

This analysis can be extended to include detailed metoprolol succinate price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Metoprolol Succinate Price

During Q4 2023, North American metoprolol succinate prices declined due to weak demand caused by inflation and interest rates. Despite an increase in output and easing inflationary pressures, prices in the US fell in December due to lower demand and consumer confidence. Manufacturers and distributors responded by offering lower quotations to clear excess inventory. Overall, prices fluctuated based on demand-supply dynamics and the economic climate.

Specific data on metoprolol succinate prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Metoprolol Succinate Price

The report explores the metoprolol succinate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on metoprolol succinate prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Metoprolol Succinate Price

The metoprolol succinate market in the APAC region during Q4 2023 saw weak demand due to subdued new orders and purchases. Adequate supply led to stable pricing, but global uncertainties and geopolitical challenges created a cautious sentiment among market participants. China's metoprolol succinate market experienced moderate price increases in Oct-Nov due to constrained supplies and festive demand, but prices declined in Dec due to reduced inquiries and sluggish exports. Global supply chain disruptions due to tensions in the Red Sea also affected Asian exports.

This analysis can be further extended to include detailed metoprolol succinate prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Metoprolol Succinate Price

The analysis of metoprolol succinate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Metoprolol Succinate
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of metoprolol succinate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting metoprolol succinate price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the metoprolol succinate industry. 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Metoprolol Succinate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More